What’s New At Embassy House?

Black and white portrait of a smiling Asian woman with her hair pulled back, wearing a black shirt, against a plain background.
A skateboard with yellow and green wheels mounted on the wall, a black and yellow backpack hanging next to it, and a framed picture of a young skateboarder performing a trick
Group of five people taking a selfie at an indoor event, smiling and having a good time.
Modern office building with signs for Forskarén, Spago Anomedical, Active Biotech, Ecophon, Carbtiq, Aventure, and Phi, featuring glass architecture and an outdoor seating area with benches and a small tree.
Why Elk Audio Left Its Traditional Office for Embassy House Medborgarplatsen
Members, Coworking, Office Embassy House Members, Coworking, Office Embassy House

Why Elk Audio Left Its Traditional Office for Embassy House Medborgarplatsen

The Stockholm-based audio technology company already had its own office. But when the team began evaluating what they needed from their workplace, they chose to move into Embassy House Medborgarplatsen instead.

For a company of eight people developing cutting-edge software for the global music technology industry, it wasn't about finding more space. It was about finding a smarter way to work.

Read More
Saveggy: Swedish Food‑Tech Innovator Moves into Embassy House and FoodWorks in Lund
Members Embassy House Members Embassy House

Saveggy: Swedish Food‑Tech Innovator Moves into Embassy House and FoodWorks in Lund

Saveggy is an innovation company from Lund that is reshaping how fresh produce is protected and distributed. With a clear mission to help the world waste less, Saveggy has developed plant‑based, edible protection for fresh fruit and vegetables that replaces traditional plastic packaging — offering a sustainable solution to food waste and plastic pollution.

Read More
Anocca Raises SEK 440 Million to Advance TCR-T Cell Therapy Development
Funding, Members Embassy House Funding, Members Embassy House

Anocca Raises SEK 440 Million to Advance TCR-T Cell Therapy Development

Anocca AB, a clinical-stage biopharmaceutical company based in Sweden, has successfully raised approximately SEK 440 million (USD 46 million) in a new financing round. This funding will accelerate the development of VIDAR-1, Anocca’s gene-edited TCR-T cell therapy targeting mutant KRAS in pancreatic cancer, and support its preclinical programs.

Read More